Product Profiles

Article

Product profiles

Preservative-free glaucoma eye drops

Taflotan, developed by Santen, is a preservative-free prostglandin eye drop tailored for glaucoma patients. The drops provide an alternative treatment for lowering intraocular pressure.

The eye drops are an ideal solution for patients who experience side effects from glaucoma eye drops with preservatives. Taflotan is also well-suited for dry and sensitive eyes.

For further information please visit http://www.santen.com/

Visual field data analysis tool

Oculus have released the Glaucoma Staging Program (GSP)- the latest software enhancement for use with the Oculus Easyfield, Centerfield 2 and Twinfield 2 perimeters.

GSP can be installed as an upgrade for any visual data analysis tools that may already be in use. It is able to detect subtle visual field changes linked to the early stages of glaucoma.

The tool performs a multi-level classification of clinical findings into either 'Normal', 'Glaucomatous', 'Artifactual' and 'Neuro'.

For further information visit http://www.oculus.de

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.